Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Preferred Stock Liabilities (2017 - 2020)

Historic Preferred Stock Liabilities for Silo Pharma (SILO) over the last 4 years, with Q2 2020 value amounting to $400000.0.

  • Silo Pharma's Preferred Stock Liabilities changed 0.0% to $400000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $400000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $400000.0 for FY2019, which is N/A changed from last year.
  • Per Silo Pharma's latest filing, its Preferred Stock Liabilities stood at $400000.0 for Q2 2020, which was down 0.0% from $400000.0 recorded in Q1 2020.
  • Silo Pharma's Preferred Stock Liabilities' 5-year high stood at $400000.0 during Q4 2017, with a 5-year trough of $400000.0 in Q4 2017.
  • Moreover, its 4-year median value for Preferred Stock Liabilities was $400000.0 (2017), whereas its average is $400000.0.
  • Over the last 5 years, Silo Pharma's Preferred Stock Liabilities had its largest YoY gain of 0.0% in 2020, and its largest YoY loss of 0.0% in 2020.
  • Silo Pharma's Preferred Stock Liabilities (Quarter) stood at $400000.0 in 2017, then changed by 0.0% to $400000.0 in 2018, then changed by 0.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020.
  • Its last three reported values are $400000.0 in Q2 2020, $400000.0 for Q1 2020, and $400000.0 during Q4 2019.